PMCTPharmaCountry
    Startseite

Regulatorische Updates

Regulatorische Entwicklungen von FDA, EMA, TGA und weltweit

#Vaginal Suppository ×

UPDATED
Regulatorische Updates
22. Sept. 2026•1 Min. Lesezeit
FDA Approves ANDA076850 for Terconazole Vaginal Suppository
FDA granted approval (ANDA076850) for Fougera Pharms' terconazole 80 mg vaginal suppository, now listed as discontinued.